Allurion Technologies (ALUR) Notes Payables (2025 - 2026)
Allurion Technologies (ALUR) reported Notes Payables of $28.6 million for Q1 2026, up 1.71% quarter-over-quarter from $28.1 million in Q4 2025.
Allurion Technologies (ALUR) Notes Payables (2025 - 2026) Analysis & Trends
Allurion Technologies has reported Notes Payables for 2 years, with the latest figure at $28.6 million in Q1 2026.
- For the quarter ending Q1 2026, Notes Payables changed N/A year-over-year to $28.6 million; the trailing twelve-month figure through Mar 2026 stood at $28.6 million (changed N/A YoY), and the FY2025 full-year result was $28.1 million, changed N/A from the prior year.
- Notes Payables for Q1 2026 stood at $28.6 million, up from $28.1 million in the prior quarter.
- The five-year high for Notes Payables was $28.6 million in Q1 2026, with the low at $28.1 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn |
| 10 | Allurion Technologies | - | - | 1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.55 Mn |
| Dec 31, 2025 | 28.07 Mn |